EUVIMEDEUVIMED entdecken
Crossref

GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety

Elisabeth Buur Stougaard, Peter Rossing iD

Nephrology Dialysis Transplantation · 30.10.2026 · 41 (11) · 1931-1933

DOI: 10.1093/ndt/gfag131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 18.06.2026. Verfasst von Elisabeth Buur Stougaard und 1 weiteren Autor:innen. Beteiligte Einrichtung: Steno Diabetes Center Copenhagen, Department of Clinical Translational Research, Herlev, Denmark. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Steno Diabetes Center Copenhagen, Department of Clinical Translational Research, Herlev, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Peter Rossing

Zitieren

APA

Stougaard, E. B., & Rossing, P. (2026). GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety. Nephrology Dialysis Transplantation, 41(11), 1931-1933. https://doi.org/10.1093/ndt/gfag131

Vancouver

Stougaard EB, Rossing P. GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety. Nephrology Dialysis Transplantation. 2026;41(11):1931-1933. doi:10.1093/ndt/gfag131

BibTeX
@article{Stougaard2026,
  author = {Stougaard, Elisabeth Buur and Rossing, Peter},
  title = {GLP-1 receptor agonists in patients with type 2 diabetes: cardiorenal protection versus ocular safety},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {1931--1933},
  doi = {10.1093/ndt/gfag131}
}
Kostenlos starten →